Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 2/20 | 0.33 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.32 |
| ▸ | PIK3C3 | Q8NEB9 | 6/20 | 0.32 |
| ▸ | BTK | Q06187 | 2/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | KMO | O15229 | 2/20 | 0.31 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.31 |
| ▸ | DHODH | Q02127 | 1/20 | 0.31 |
| ▸ | VRK1 | Q99986 | 1/20 | 0.30 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22167063 | 0.83 | PTGS2 (0.35) | RPS6KA3PTGS2GPBAR1NFE2L2 | |
| SCHEMBL22167066 | 0.82 | RPS6KA3 (0.31) | RPS6KA3 | |
| SCHEMBL25848930 | 0.81 | MTOR (0.34) | ERN1KMO | |
| SCHEMBL24037150 | 0.78 | HDAC1 (0.40) | KMOGPBAR1DHODH | |
| SCHEMBL21870524 | 0.76 | NFE2L2 (0.42) | PTGS2KMONFE2L2 | |
| SCHEMBL31058914 | 0.74 | TGFBR1 (0.36) | PTGS2KMOGPBAR1NFE2L2 | |
| SCHEMBL22167086 | 0.74 | TGFBR1 (0.36) | PTGS2KMOGPBAR1NFE2L2 | |
| SCHEMBL8550487 | 0.74 | MEN1 (0.39) | RPS6KA3PTGS2 | |
| SCHEMBL25669642 | 0.74 | TDP1 (0.40) | PTGS2KMONFE2L2 | |
| SCHEMBL23557303 | 0.74 | ABL1 (0.43) | ERN1DHODH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11800788-B2 | Organometallic compound and organic light-emitting device including i he same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-10-24 | — | — | US | disclosed |
| US-11800788-B2 | Organometallic compound and organic light-emitting device including i he same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-10-24 | — | — | US | disclosed |
| US-20200212319-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11800788-B2 | Organometallic compound and organic light-emitting device including i he same | UBE2L3, CRY1, OR10J3 | ERN1 1906/4885RPS6KA3 1575/4885PIK3C3 2820/4885 |
| US-20200212319-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | OR10J3, UBE2L3, NR2E3 | ERN1 2146/4885RPS6KA3 1208/4885PIK3C3 3210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.